🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05238623
Starting soon Observational

Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19

NCT05238623 · tracked via the Priya Life Science Germany tracker
Sponsor
Jan-Christoph Lewejohann
Phase
Observational
Started
2025-10-01
Last updated
2025-09-25

Condition(s) studied

COVID-19 PneumoniaPost-acute COVID-19 SyndromeElectric Impedance

Investigational drug(s) / intervention(s)

additional EIT Measurement

additional EIT Measurement: Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.

Study summary

Investigation of the correlation of CT-morphological changes of the lung compared to regional ventilation distribution on electrical impedance tomography in patients with post-acute-Covid-19 symptoms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * all patients undergoing a Chest CT due to suspected post-acute-Covid-19-syndrome * \>18 years * informed consent. Exclusion Criteria: * trauma patients and patients with unstable spinal injuries or fractures * patients with an BMI over 50 * patients with uncontrolled body movements * Patients with a pacemaker

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Klinik für Notfallmedizin Jena Thuringia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05238623 on ClinicalTrials.gov ↗ ← All trials in Germany